SCHEMBL14164238

SCHEMBL14164238

CC(C)(C)OC(=O)N1CCN(c2nnc(C(=O)O)[nH]2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 1/20 0.44
▸ KIT P10721 1/20 0.43
▸ CKS1B P61024 2/20 0.43
▸ SKP1 P63208 2/20 0.43
▸ SKP2 Q13309 2/20 0.43
▸ ALDH1A1 P00352 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ ACHE P22303 1/20 0.42
▸ NAMPT P43490 1/20 0.41
▸ USP2 O75604 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ ATM Q13315 1/20 0.41
▸ SMARCA2 P51531 1/20 0.41
▸ SMARCA4 P51532 1/20 0.41
▸ PBRM1 Q86U86 1/20 0.41
▸ GPR119 Q8TDV5 3/20 0.40
▸ PARP1 P09874 1/20 0.40
▸ MAP4K4 O95819 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2146977 0.87 KCNH2 (0.45) KCNH2KITCKS1BSKP1SKP2
SCHEMBL10168030 0.82 KCNH2 (0.45) KCNH2KITCKS1BSKP1SKP2
SCHEMBL18294 0.72 USP2 (0.69) ALDH1A1LMNAMAPTUSP2SMN1; SMN2
SCHEMBL698803 0.72 USP2 (0.69) ALDH1A1LMNAMAPTUSP2SMN1; SMN2
SCHEMBL10297496 0.71 GPR119 (0.55) CKS1BSKP1SKP2ALDH1A1LMNA
SCHEMBL16825695 0.70 MAP4K4 (0.46) KCNH2KITCKS1BSKP1SKP2
SCHEMBL16196931 0.69 GPR119 (0.47) CKS1BSKP1SKP2ALDH1A1LMNA
SCHEMBL28101296 0.69 CKS1B (0.50) KITCKS1BSKP1SKP2ALDH1A1
SCHEMBL20897769 0.69 HTR3A (0.62) —
SCHEMBL23960997 0.69 GPR119 (0.53) CKS1BSKP1SKP2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080139535-A1 INHIBITORS OF HISTONE DEACETYLASE MIIKANA THERAPEUTICS 2008-06-12 — — US disclosed
US-20080139535-A1 INHIBITORS OF HISTONE DEACETYLASE MIIKANA THERAPEUTICS 2008-06-12 — — US disclosed
US-7345043-B2 Inhibitors of histone deacetylase MIIKANA THERAPEUTICS (US) 2008-03-18 — — US disclosed
US-7345043-B2 Inhibitors of histone deacetylase MIIKANA THERAPEUTICS (US) 2008-03-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080139535-A1 INHIBITORS OF HISTONE DEACETYLASE HDAC1, HDAC11, HDAC10 KCNH2 4520/4885KIT 2727/4885CKS1B 112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback